Volatility Spike may Give way to Opportunity in Biotech ETFs

The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotech ETF by assets, and other biotech ETFs proved vulnerable to the broader market’s recent surge in volatility, but the declines endured by IBB and friends could prove to be a buying opportunity for astute investors. Given...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.